Next Generation Biopharmaceutical Downstream Process is a European-funded collaborative project that aims at implementing a fully integrated manufacturing platform for biosimilar mAb based on continuous chromatography, in combination with single-use disposable technologies for all unit operations of DSP on pilot/small production scale together with incorporation of advanced analytical tools. In this webinar you will learn about a new DSP purification template producing > 3.3 kg of mAb in 2.5 days in less than 30m² and proof-of-concept for the mAb manufacturing of tomorrow.
Watch Webinar